Related Experiment Video
Updated: Aug 17, 2026

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
Published on: August 21, 2013
PKCdelta and MAPK mediate G(1) arrest induced by PMA in SKBR-3 breast cancer cells
Goro Yokoyama1, Teruhiko Fujii, Kosuke Tayama
1Department of Surgery, Kurume University School of Medicine, 67 Asahimachi, Fukuoka 830-0011, Japan.
Abstract:
The effects of activating endogenous protein kinase C (PKC) on cell proliferation and the cell cycle were investigated by treating the breast cancer cell line SKBR-3 with phorbol 12-myristate 13 acetate (PMA). This inhibited cell growth in a concentration-dependent manner, causing a marked arrest of cells in G(1). Pre-treatment with GF109203X completely blocked the antiproliferative effect of PMA, and pre-treatment with the PKCdelta inhibitor rottlerin partially blocked it. Infecting SKBR-3 cells with an adenovirus vector containing wild-type PKCdelta, WTPKCdeltaAdV, had similar effects on PMA. Infecting the cells with a dominant-negative PKCdeltaAdV construct blocked the growth inhibition induced by PMA. Downstream of PKC, PMA treatment inhibited extracellular signal-regulated kinase mitogen-activated protein kinase phosphorylation, up-regulated c-jun NH(2)-terminal kinase phosphorylation, and inhibited retinoblastoma (Rb) phosphorylation. These results strongly implicated PKC (mainly PKCdelta) in the G(1) arrest induced by PMA and suggested PKC as a target for breast cancer treatment.
Insights
Activating protein kinase C (PKC) with PMA inhibits breast cancer cell growth and causes G(1) cell cycle arrest. This effect is mediated primarily by PKCdelta, suggesting PKC as a therapeutic target.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Protein Kinase C (PKC) plays a role in cell signaling pathways.
- Dysregulation of cell proliferation is a hallmark of cancer.
- Targeting cell cycle regulators is a strategy for cancer therapy.
Purpose of the Study:
- To investigate the effects of activating endogenous protein kinase C (PKC) on breast cancer cell proliferation and cell cycle.
- To elucidate the specific PKC isoforms involved in these processes.
- To evaluate PKC as a potential therapeutic target for breast cancer.
Main Methods:
- Treatment of SKBR-3 breast cancer cells with phorbol 12-myristate 13 acetate (PMA).
- Use of specific PKC inhibitors (GF109203X, rottlerin) and adenovirus vectors (WTPKCdeltaAdV, dominant-negative PKCdeltaAdV).
- Analysis of cell cycle progression (G(1) arrest) and downstream signaling pathways (ERK, JNK, Rb phosphorylation).
Main Results:
- PMA inhibited SKBR-3 cell growth in a concentration-dependent manner, inducing G(1) arrest.
- PKCdelta was identified as the primary mediator of PMA's antiproliferative effects.
- PMA modulated downstream signaling, inhibiting ERK and Rb phosphorylation while up-regulating JNK phosphorylation.
Conclusions:
- PKC activation, particularly via PKCdelta, induces G(1) cell cycle arrest in breast cancer cells.
- PKC signaling pathways are crucial in regulating cell proliferation in breast cancer.
- PKC represents a promising therapeutic target for breast cancer treatment.
More Related Videos
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
MAPK Signaling Cascades